Abstract
Estrogen receptor alpha (ER) is the target of endocrine therapies in ER-positive breast cancer (BC), but their therapeutic effectiveness diminishes wi......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
